Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Sebastian Hofbauer"'
Autor:
Kira Furlano, Henning Plage, Sebastian Hofbauer, Sarah Weinberger, Bernhard Ralla, Annika Fendler, Florian Roßner, Simon Schallenberg, Sefer Elezkurtaj, Martina Kluth, Maximilian Lennartz, Niclas C. Blessin, Andreas H. Marx, Henrik Samtleben, Margit Fisch, Michael Rink, Marcin Slojewski, Krystian Kaczmarek, Thorsten Ecke, Stefan Koch, Nico Adamini, Sarah Minner, Ronald Simon, Guido Sauter, Joachim Weischenfeldt, Tobias Klatte, Thorsten Schlomm, David Horst, Henrik Zecha
Publikováno v:
BJUI Compass, Vol 5, Iss 11, Pp 1081-1089 (2024)
Abstract Objective There is a shortage of established prognostic biomarkers in bladder cancer. One candidate is tumour protein 63 (p63), a transcription factor of the p53 gene family that is expressed in the normal urothelium. Recently proposed RNA e
Externí odkaz:
https://doaj.org/article/858134d5041e486092630ed50c6fad55
Autor:
Henning Plage, Kira Furlano, Sebastian Hofbauer, Sarah Weinberger, Bernhard Ralla, Antonia Franz, Annika Fendler, Michela de Martino, Florian Roßner, Sefer Elezkurtaj, Martina Kluth, Maximilian Lennartz, Niclas C. Blessin, Andreas H. Marx, Henrik Samtleben, Margit Fisch, Michael Rink, Marcin Slojewski, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Henrik Zecha, Sarah Minner, Ronald Simon, Guido Sauter, Joachim Weischenfeldt, Tobias Klatte, Thorsten Schlomm, David Horst, Simon Schallenberg
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background A high level of PD-L1 expression is the most relevant predictive parameter for response to immune checkpoint inhibitor (CPI) therapy in urinary bladder cancer. Existing data on the relationship between PD-L1 expression and the nat
Externí odkaz:
https://doaj.org/article/2e11c11592e44f26b250abef630710aa
Autor:
Jan H. Müller, Henning Plage, Sefer Elezkurtaj, Tim Mandelkow, Zhihao Huang, Magalie C. J. Lurati, Jonas B. Raedler, Nicolaus F. Debatin, Eik Vettorazzi, Henrik Samtleben, Sebastian Hofbauer, Kira Furlano, Jörg Neymeyer, Irena Goranova, Bernhard Ralla, Sarah Weinberger, David Horst, Florian Roßner, Simon Schallenberg, Andreas H. Marx, Margit Fisch, Michael Rink, Marcin Slojewski, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Maximilian Lennartz, Sarah Minner, Ronald Simon, Guido Sauter, Henrik Zecha, Thorsten Schlomm, Elena Bady
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
IntroductionTrophoblast cell surface antigen 2 (TROP2; EpCAM2) is a transmembrane glycoprotein which is closely related to EpCAM (EpCAM; EpCAM1). Both proteins share partial overlapping functions in epithelial development and EpCAM expression but hav
Externí odkaz:
https://doaj.org/article/e1665b34d1bc44738c48bdeeea0208d5
Autor:
Hannes Cash, Sebastian Hofbauer, Neal Shore, Christian P. Pavlovich, Stephan Bulang, Martin Schostak, Erik Planken, Joris J. Jaspars, Ferdinand Luger, Laurence Klotz, Georg Salomon
Publikováno v:
Société Internationale d’Urologie Journal, Vol 3, Iss 2, Pp 62-68 (2022)
ObjectiveMicro-ultrasound is an imaging modality used to visualize and target prostate cancer during transrectal or transperineal biopsy. We evaluated the effectiveness of a micro-ultrasound training program and estimated the learning curve for prost
Externí odkaz:
https://doaj.org/article/87fb3491f32a4962ad8096638b37f873
Autor:
Charlie A. Hamm, Georg L. Baumgärtner, Felix Biessmann, Nick L. Beetz, Alexander Hartenstein, Lynn J. Savic, Konrad Froböse, Franziska Dräger, Simon Schallenberg, Madhuri Rudolph, Alexander D. J. Baur, Bernd Hamm, Matthias Haas, Sebastian Hofbauer, Hannes Cash, Tobias Penzkofer
Publikováno v:
Radiology. 307
Autor:
Sebastian Hofbauer
Publikováno v:
Responsible Leadership ISBN: 9781003129189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3aaca9e0b1f0480f3d52bed63286822
https://doi.org/10.4324/9781003129189-27
https://doi.org/10.4324/9781003129189-27
Autor:
Paul Giacomo Bruch, Henning Plage, Sebastian Hofbauer, Kira Kornienko, Sarah Weinberger, Florian Roßner, Simon Schallenberg, Martina Kluth, Maximilian Lennartz, Niclas C. Blessin, Andreas H. Marx, Henrik Samtleben, Margit Fisch, Michael Rink, Marcin Slojewski, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Sarah Minner, Ronald Simon, Guido Sauter, Henrik Zecha, Tobias Klatte, Thorsten Schlomm, David Horst, Sefer Elezkurtaj
Publikováno v:
Experimental and Molecular Pathology. 131:104860
Autor:
Henning Plage, Henrik Samtleben, Sebastian Hofbauer, Kira Kornienko, Sarah Weinberger, Paul Giacomo Bruch, Sefer Elezkurtaj, Florian Roßner, Simon Schallenberg, Martina Kluth, Maximilian Lennartz, Niclas C. Blessin, Andreas H. Marx, Margit Fisch, Michael Rink, Marcin Slojewski, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Sarah Minner, Ronald Simon, Guido Sauter, Tobias Klatte, Thorsten Schlomm, David Horst, Henrik Zecha
Publikováno v:
Human pathology. 130
The transcription factor GATA binding protein 3 (GATA3) is commonly used in surgical pathology as a diagnostic marker to distinguish urothelial carcinomas from other cancer entities. However, the clinical relevance of GATA3 expression in urothelial b
Autor:
Nick Lasse Beetz, Franziska Dräger, Charlie Alexander Hamm, Seyd Shnayien, Madhuri Monique Rudolph, Konrad Froböse, Sefer Elezkurtaj, Matthias Haas, Patrick Asbach, Bernd Hamm, Samy Mahjoub, Frank Konietschke, Maximilian Wechsung, Felix Balzer, Hannes Cash, Sebastian Hofbauer, Tobias Penzkofer
Publikováno v:
Prostate cancer and prostatic diseases.
Background Magnetic resonance imaging (MRI) is used to detect the prostate index lesion before targeted biopsy. However, the number of biopsy cores that should be obtained from the index lesion is unclear. The aim of this study is to analyze how many
Autor:
Martin S Hennig, Serkan Dogan, Sebastian Hofbauer, Franz F Dressler, Julian P. Struck, Tanja Frank, Johannes Salem, Hendrik Borgmann, Mario W. Kramer, Tobias Klatte, Angelika Cebulla
Publikováno v:
Aktuelle Urologie. 52:82-87
Zusammenfassung Hintergrund und Zielsetzung Die radikale Zystektomie (RCX) ist die kurative Standardbehandlung für muskelinvasive Harnblasenkarzinome. Aufgrund des operativen Ausmaßes und der damit verbundenen komplexen stationären Betreuung ist d